Pillstats
Rx only · Solution · Oral

Lacosamide

Brands: Vimpat · Lacosamide

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN03AX18
RxCUI (US)623400
US makers18 labelers
Packages41
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.086$0.172$0.258$0.344Dec 2025Apr 2026Jul 2026
$0.256
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
18
Active US suppliers
27%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

18K36K53K71K2025 Q12025 Q22025 Q32025 Q42026 Q1
54K
Rx · 2026 Q1
33.2M
Units dispensed
+14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novadoz Pharmaceuticals LLCunknown6SUPPLYING
Kesin Pharma Corporationunknown5SUPPLYING
PAI Holdings, LLC dba PAI Pharmaunknown4SUPPLYING
American Health Packagingunknown3SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
Kanchan Healthcare Incunknown2SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
Camber Pharmaceuticals, Inc.unknown2SUPPLYING
Leading Pharma, LLCunknown2SUPPLYING
Chartwell Governmental & Specialty RX, LLC.unknown2SUPPLYING
Precision Dose, Inc.unknown2SUPPLYING
GLENMARK PHARMACEUTICALS INCunknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Ajenat Pharmaceuticals LLCunknown1SUPPLYING

+ 3 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 6, 2022
    RECALLRecall (Class III): Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceutical…

    Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content — Recalling firm: Camber Pharmaceuticals, Inc — USA Nationwide